Products
Platform
Research
Market
Learn
Compare UTI Healthcare Fund vs SBI Healthcare Opportunities Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 4.0 | 5.0 |
Min SIP Amount | ₹500 | ₹500 |
Expense Ratio | 2.25 | 1.93 |
NAV | ₹296.34 | ₹435.81 |
Fund Started | 01 Aug 2005 | 04 Jun 1999 |
Fund Size | ₹1118.41 Cr | ₹3963.38 Cr |
Exit Load | Exit load of 1% if redeemed within 30 days. | Exit load of 0.50% if redeemed within 15 days |
Risk
Very High
Very High
Rating
4.0
5.0
Min SIP Amount
₹500
₹500
Expense Ratio
2.25
1.93
NAV
₹296.34
₹435.81
Fund Started
01 Aug 2005
04 Jun 1999
Fund Size
₹1118.41 Cr
₹3963.38 Cr
Exit Load
Exit load of 1% if redeemed within 30 days.
Exit load of 0.50% if redeemed within 15 days
Returns
1 Year | 2.28% | 3.61% |
3 Year | 25.64% | 26.15% |
5 Year | 19.27% | 20.80% |
1 Year
2.28%
3.61%
3 Year
25.64%
26.15%
5 Year
19.27%
20.80%
Holding Analysis
Equity | 99.35% | 96.19% |
Cash | 0.64% | 3.74% |
Equity
99.35%
96.19%
Cash
0.64%
3.74%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 9.42% |
Cipla Ltd. | 5.68% |
Ajanta Pharma Ltd. | 5.38% |
Lupin Ltd. | 4.57% |
Dr. Reddy's Laboratories Ltd. | 4.06% |
Procter & Gamble Health Ltd. | 3.99% |
Fortis Healthcare Ltd. | 3.79% |
Glenmark Pharmaceuticals Ltd. | 3.78% |
Apollo Hospitals Enterprise Ltd. | 3.61% |
Alkem Laboratories Ltd. | 3.41% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 10.86% |
Divi's Laboratories Ltd. | 6.81% |
Max Healthcare Institute Ltd. | 6.12% |
Cipla Ltd. | 4.81% |
Lonza Group Ag | 4.24% |
Lupin Ltd. | 4.02% |
Torrent Pharmaceuticals Ltd. | 3.59% |
Mankind Pharma Ltd. | 3.49% |
Fortis Healthcare Ltd. | 3.45% |
Gland Pharma Ltd. | 3.31% |
Fund Manager
Name | Kamal Gada | Tanmaya Desai |
Start Date | 02 May 2022 | 27 Jun 2011 |
Name
Kamal Gada
Tanmaya Desai
Start Date
02 May 2022
27 Jun 2011
About Fund
Description | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 01 Aug 2005 | 04 Jun 1999 |
Description
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
01 Aug 2005
04 Jun 1999
